{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["40(1)"],"submitter":["Ambroz M"],"funding":["Horizon 2020 Framework Programme","European Commission","H2020 Marie Skłodowska-Curie Actions"],"pubmed_abstract":["<h4>Background</h4>Sex differences in clinical outcomes have been observed for patients with type 2 diabetes mellitus (T2DM). These could be related to sex disparities in treatment.<h4>Objectives</h4>To determine whether there are sex disparities in medication prescribing amongst patients with T2DM.<h4>Methods</h4>A cohort study was conducted using the Groningen Initiative to ANalyze Type 2 diabetes Treatment (GIANTT) database, which includes data from primary care patients with T2DM from the north of the Netherlands. Data on demographics, physical examinations, laboratory measurements and prescribing were extracted. A set of validated prescribing quality indicators assessing the prevalence, start, intensification and safety of glucose-, lipid-, blood pressure- and albuminuria-lowering med"],"journal":["Diabetic medicine : a journal of the British Diabetic Association"],"pagination":["e14987"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10098565"],"repository":["biostudies-literature"],"pubmed_title":["Sex disparities in medication prescribing amongst patients with type 2 diabetes mellitus managed in primary care."],"pmcid":["PMC10098565"],"pubmed_authors":["Geelink M","Smits KPJ","Denig P","de Vries ST","Ambroz M"],"additional_accession":[]},"is_claimable":false,"name":"Sex disparities in medication prescribing amongst patients with type 2 diabetes mellitus managed in primary care.","description":"<h4>Background</h4>Sex differences in clinical outcomes have been observed for patients with type 2 diabetes mellitus (T2DM). These could be related to sex disparities in treatment.<h4>Objectives</h4>To determine whether there are sex disparities in medication prescribing amongst patients with T2DM.<h4>Methods</h4>A cohort study was conducted using the Groningen Initiative to ANalyze Type 2 diabetes Treatment (GIANTT) database, which includes data from primary care patients with T2DM from the north of the Netherlands. Data on demographics, physical examinations, laboratory measurements and prescribing were extracted. A set of validated prescribing quality indicators assessing the prevalence, start, intensification and safety of glucose-, lipid-, blood pressure- and albuminuria-lowering med","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jan","modification":"2025-04-18T21:20:15.13Z","creation":"2025-02-18T23:40:14.711Z"},"accession":"S-EPMC10098565","cross_references":{"pubmed":["36278892"],"doi":["10.1111/dme.14987"]}}